RxDoctor Payments Data

Elizabeth Mirkin, MD

Psychiatry · Chicago, ILNPI 1407848286

Payments from drug & device makers

$1,279in general payments, 2019–2025

Across 70 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$609
  • Otsuka America Pharmaceutical, Inc.$218
  • AbbVie$162
  • Lundbeck LLC$112
  • Takeda Pharmaceuticals U.S.A., Inc.$66
  • Sunovion Pharmaceuticals Inc.$62
  • plus $51 from 3 others

What the payments were for

  • Food & beverage$1,279100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,279 in reported general payments places this provider in the 75th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$57,480
Medicare patients
133
Services billed
556

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate16$146,667
AustedoDeutetrabenazine22$120,962
Invega SustennaPaliperidone Palmitate35$103,203
Abilify MaintenaAripiprazole29$74,686
Lurasidone Hcl60$73,599
RexultiBrexpiprazole34$49,766
TrintellixVortioxetine Hydrobromide83$46,597
Aripiprazole189$35,779
VraylarCariprazine Hcl11$17,200
Doxepin Hcl55$6,686
Memantine Hcl98$5,996
Bupropion XlBupropion Hcl281$5,673
Ziprasidone Hcl54$3,998
Prazosin Hcl97$3,630
Vilazodone Hcl49$3,469

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$27$146,66716 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$218$124,45363 claims
Teva Pharmaceuticals USA, Inc.Austedo$13$120,96222 claims
Johnson & JohnsonInvega Sustenna$609$103,20335 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$66$46,59783 claims
AbbVieVraylar$162$17,20011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →